Literature DB >> 6877329

Gm allotypes in membranous nephropathy.

P Brenchley, J Feehally, P Doré, B Coupes, C D Short, R S Pumphrey, N P Mallick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6877329     DOI: 10.1056/NEJM198309013090914

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Cognitive effects of high-dose naltrexone in patients with probable Alzheimer's disease.

Authors:  D S Knopman; M Hartman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

Review 2.  Neurotransmitter replacement therapy in Alzheimer's disease.

Authors:  E Mohr; T Mendis; I N Rusk; J D Grimes
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

3.  Effect of naltrexone on senile dementia of the Alzheimer type.

Authors:  B T Hyman; P J Eslinger; A R Damasio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

4.  Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3.

Authors:  J Feehally; P E Brenchley; B M Coupes; N P Mallick; D M Morris; C D Short
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.